{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:11:35Z","timestamp":1791216695650,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a vascular remodeling disease characterized by enhanced proliferation of pulmonary artery smooth muscle cell (PASMC) and suppressed apoptosis. This phenotype has been associated with the upregulation of the oncoprotein survivin promoting mitochondrial membrane potential hyperpolarization (decreasing apoptosis) and the upregulation of growth factor and cytokines like PDGF, IL-6 and vasoactive agent like endothelin-1 (ET-1) promoting PASMC proliferation. Kr\u00fcppel-like factor 5 (KLF5), is a zinc-finger-type transcription factor implicated in the regulation of cell differentiation, proliferation, migration and apoptosis. Recent studies have demonstrated the implication of KLF5 in tissue remodeling in cardiovascular diseases, such as atherosclerosis, restenosis, and cardiac hypertrophy. Nonetheless, the implication of KLF5 in pulmonary arterial hypertension (PAH) remains unknown. We hypothesized that KLF5 up-regulation in PAH triggers PASMC proliferation and resistance to apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We showed that KFL5 is upregulated in both human lung biopsies and cultured human PASMC isolated from distal pulmonary arteries from PAH patients compared to controls. Using stimulation experiments, we demonstrated that PDGF, ET-1 and IL-6 trigger KLF-5 activation in control PASMC to a level similar to the one seen in PAH-PASMC. Inhibition of the STAT3 pathway abrogates KLF5 activation in PAH-PASMC. Once activated, KLF5 promotes cyclin B1 upregulation and promotes PASMC proliferation and triggers survivin expression hyperpolarizing mitochondria membrane potential decreasing PASMC ability to undergo apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We demonstrated for the first time that KLF5 is activated in human PAH and implicated in the pro-proliferative and anti-apoptotic phenotype that characterize PAH-PASMC. We believe that our findings will open new avenues of investigation on the role of KLF5 in PAH and might lead to the identification of new therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1465-9921-12-128","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T03:01:24Z","timestamp":1317178884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Kr\u00fcppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension"],"prefix":"10.1186","volume":"12","author":[{"given":"Audrey","family":"Courboulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique L","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Barrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyane","family":"Meloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Chapolard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Bisserier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Paulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"issue":"2","key":"1152_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE: An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992, 327 (2): 70-75. 10.1056\/NEJM199207093270202.","journal-title":"N Engl J Med"},{"issue":"1","key":"1152_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.RES.81.1.34","volume":"81","author":"W Steudel","year":"1997","unstructured":"Steudel W, Ichinose F, Huang PL, Hurford WE, Jones RC, Bevan JA, Fishman MC, Zapol WM: Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res. 1997, 81 (1): 34-41.","journal-title":"Circ Res"},{"issue":"6","key":"1152_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"DJ Stewart","year":"1991","unstructured":"Stewart DJ, Levy RD, Cernacek P, Langleben D: Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?. Ann Intern Med. 1991, 114 (6): 464-469.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1152_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","volume":"178","author":"F Perros","year":"2008","unstructured":"Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, et al: Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008, 178 (1): 81-88. 10.1164\/rccm.200707-1037OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"1152_CR5","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","volume":"113","author":"S Bonnet","year":"2006","unstructured":"Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, et al: An abnormal mitochondrial-hypoxia inducible factor-1 alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation. 2006, 113 (22): 2630-2641. 10.1161\/CIRCULATIONAHA.105.609008.","journal-title":"Circulation"},{"issue":"27","key":"1152_CR6","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.0610467104","volume":"104","author":"S Bonnet","year":"2007","unstructured":"Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, Hashimoto K, Bonnet SN, Michelakis ED: The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA. 2007, 104 (27): 11418-11423. 10.1073\/pnas.0610467104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1152_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI23203","volume":"115","author":"MS McMurtry","year":"2005","unstructured":"McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Bonnet S, Puttagunta L, Michelakis ED: Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest. 2005, 115 (6): 1479-1491. 10.1172\/JCI23203.","journal-title":"J Clin Invest"},{"issue":"1-2","key":"1152_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cca.2009.01.018","volume":"403","author":"P Yildiz","year":"2009","unstructured":"Yildiz P: Molecular mechanisms of pulmonary hypertension. Clin Chim Acta. 2009, 403 (1-2): 9-16. 10.1016\/j.cca.2009.01.018.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1152_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2010.02.003","volume":"126","author":"E Dumas de la Roque","year":"2010","unstructured":"Dumas de la Roque E, Savineau JP, Bonnet S: Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension. Pharmacol Ther. 2010, 126 (2): 186-199. 10.1016\/j.pharmthera.2010.02.003.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1152_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1183\/09031936.00078207","volume":"31","author":"J Dupuis","year":"2008","unstructured":"Dupuis J, Hoeper MM: Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J. 2008, 31 (2): 407-415. 10.1183\/09031936.00078207.","journal-title":"Eur Respir J"},{"issue":"4","key":"1152_CR11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1213\/01.ane.0000278736.81133.26","volume":"105","author":"B Li","year":"2007","unstructured":"Li B, Yang L, Shen J, Wang C, Jiang Z: The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1\/2 phosphorylation. Anesth Analg. 2007, 105 (4): 1034-1041. 10.1213\/01.ane.0000278736.81133.26. table of contents","journal-title":"Anesth Analg"},{"issue":"13","key":"1152_CR12","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMc051946","volume":"353","author":"HA Ghofrani","year":"2005","unstructured":"Ghofrani HA, Seeger W, Grimminger F: Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med. 2005, 353 (13): 1412-1413. 10.1056\/NEJMc051946.","journal-title":"N Engl J Med"},{"issue":"22","key":"1152_CR13","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1161\/01.CIR.102.22.2781","volume":"102","author":"S Archer","year":"2000","unstructured":"Archer S, Rich S: Primary pulmonary hypertension: a vascular biology and translational research \"Work in progress\". Circulation. 2000, 102 (22): 2781-2791.","journal-title":"Circulation"},{"issue":"16","key":"1152_CR14","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00018-009-0045-z","volume":"66","author":"JT Dong","year":"2009","unstructured":"Dong JT, Chen C: Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 2009, 66 (16): 2691-2706. 10.1007\/s00018-009-0045-z.","journal-title":"Cell Mol Life Sci"},{"issue":"25","key":"1152_CR15","doi-asserted-by":"publisher","first-page":"16791","DOI":"10.1074\/jbc.M808919200","volume":"284","author":"R Liu","year":"2009","unstructured":"Liu R, Zheng HQ, Zhou Z, Dong JT, Chen C: KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem. 2009, 284 (25): 16791-16798. 10.1074\/jbc.M808919200.","journal-title":"J Biol Chem"},{"issue":"6","key":"1152_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ijc.21533","volume":"118","author":"C Chen","year":"2006","unstructured":"Chen C, Benjamin MS, Sun X, Otto KB, Guo P, Dong XY, Bao Y, Zhou Z, Cheng X, Simons JW, et al: KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer. 2006, 118 (6): 1346-1355. 10.1002\/ijc.21533.","journal-title":"Int J Cancer"},{"issue":"2","key":"1152_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000073043","volume":"100","author":"H Sakamoto","year":"2003","unstructured":"Sakamoto H, Sakamaki T, Kanda T, Hoshino Y, Sawada Y, Sato M, Sato H, Oyama Y, Nakano A, Takase S, et al: Smooth muscle cell outgrowth from coronary atherectomy specimens in vitro is associated with less time to restenosis and expression of a key Transcription factor KLF5\/BTEB2. Cardiology. 2003, 100 (2): 80-85. 10.1159\/000073043.","journal-title":"Cardiology"},{"issue":"8","key":"1152_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1538-7836.2005.01366.x","volume":"3","author":"R Nagai","year":"2005","unstructured":"Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I: Significance of the transcription factor KLF5 in cardiovascular remodeling. J Thromb Haemost. 2005, 3 (8): 1569-1576. 10.1111\/j.1538-7836.2005.01366.x.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1152_CR19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm738","volume":"8","author":"T Shindo","year":"2002","unstructured":"Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, et al: Kruppel-like zinc-finger transcription factor KLF5\/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002, 8 (8): 856-863.","journal-title":"Nat Med"},{"issue":"1","key":"1152_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","volume":"11","author":"S Bonnet","year":"2007","unstructured":"Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, et al: A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007, 11 (1): 37-51. 10.1016\/j.ccr.2006.10.020.","journal-title":"Cancer Cell"},{"issue":"13","key":"1152_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCULATIONAHA.109.848911","volume":"120","author":"S Bonnet","year":"2009","unstructured":"Bonnet S, Paulin R, Sutendra G, Dromparis P, Roy M, Watson KO, Nagendran J, Haromy A, Dyck JR, Michelakis ED: Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt\/GSK3-{beta}\/NFAT axis. Circulation. 2009, 120 (13): 1231-1240. 10.1161\/CIRCULATIONAHA.109.848911.","journal-title":"Circulation"},{"issue":"2","key":"1152_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.pharmthera.2008.08.002","volume":"120","author":"K Boengler","year":"2008","unstructured":"Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R: The myocardial JAK\/STAT pathway: from protection to failure. Pharmacol Ther. 2008, 120 (2): 172-185. 10.1016\/j.pharmthera.2008.08.002.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"1152_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.vph.2005.08.021","volume":"43","author":"K Grote","year":"2005","unstructured":"Grote K, Luchtefeld M, Schieffer B: JANUS under stress--role of JAK\/STAT signaling pathway in vascular diseases. Vascul Pharmacol. 2005, 43 (5): 357-363. 10.1016\/j.vph.2005.08.021.","journal-title":"Vascul Pharmacol"},{"issue":"5332","key":"1152_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr","year":"1997","unstructured":"Darnell JE: STATs and gene regulation. Science. 1997, 277 (5332): 1630-1635. 10.1126\/science.277.5332.1630.","journal-title":"Science"},{"issue":"2","key":"1152_CR25","doi-asserted-by":"publisher","first-page":"H1291","DOI":"10.1152\/ajpheart.00181.2007","volume":"293","author":"AK Banes-Berceli","year":"2007","unstructured":"Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock DM, Marrero MB: Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol. 2007, 293 (2): H1291-1299. 10.1152\/ajpheart.00181.2007.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1152_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","volume":"54","author":"A Csiszar","year":"2009","unstructured":"Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, et al: Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension. 2009, 54 (3): 668-675. 10.1161\/HYPERTENSIONAHA.109.133397.","journal-title":"Hypertension"},{"issue":"10","key":"1152_CR27","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, et al: Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005, 115 (10): 2811-2821. 10.1172\/JCI24838.","journal-title":"J Clin Invest"},{"issue":"2 Pt 1","key":"1152_CR28","first-page":"L304","volume":"276","author":"HF Frasch","year":"1999","unstructured":"Frasch HF, Marshall C, Marshall BE: Endothelin-1 is elevated in monocrotaline pulmonary hypertension. Am J Physiol. 1999, 276 (2 Pt 1): L304-310.","journal-title":"Am J Physiol"},{"issue":"8","key":"1152_CR29","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/stem.110","volume":"27","author":"PY Bourillot","year":"2009","unstructured":"Bourillot PY, Aksoy I, Schreiber V, Wianny F, Schulz H, Hummel O, Hubner N, Savatier P: Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells. 2009, 27 (8): 1760-1771. 10.1002\/stem.110.","journal-title":"Stem Cells"},{"issue":"1","key":"1152_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bbrc.2009.11.145","volume":"391","author":"E Amirak","year":"2010","unstructured":"Amirak E, Zakkar M, Evans PC, Kemp PR: Perfusion of veins at arterial pressure increases the expression of KLF5 and cell cycle genes in smooth muscle cells. Biochem Biophys Res Commun. 2010, 391 (1): 818-823. 10.1016\/j.bbrc.2009.11.145.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"1152_CR31","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.febslet.2005.07.053","volume":"579","author":"MO Nandan","year":"2005","unstructured":"Nandan MO, Chanchevalap S, Dalton WB, Yang VW: Kruppel-like factor 5 promotes mitosis by activating the cyclin B1\/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett. 2005, 579 (21): 4757-4762. 10.1016\/j.febslet.2005.07.053.","journal-title":"FEBS Lett"},{"issue":"11","key":"1152_CR32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4161\/cbt.4.11.2090","volume":"4","author":"Y Yang","year":"2005","unstructured":"Yang Y, Goldstein BG, Chao HH, Katz JP: KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther. 2005, 4 (11): 1216-1221. 10.4161\/cbt.4.11.2090.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"1152_CR33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/jb\/mvp115","volume":"146","author":"M He","year":"2009","unstructured":"He M, Han M, Zheng B, Shu YN, Wen JK: Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. J Biochem. 2009, 146 (5): 683-691. 10.1093\/jb\/mvp115.","journal-title":"J Biochem"},{"issue":"11","key":"1152_CR34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/01.RES.0000190613.22565.13","volume":"97","author":"K Fujiu","year":"2005","unstructured":"Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G, Shindo T, Maemura K, Kagechika H, Shudo K, et al: Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res. 2005, 97 (11): 1132-1141. 10.1161\/01.RES.0000190613.22565.13.","journal-title":"Circ Res"},{"issue":"6","key":"1152_CR35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI23203","volume":"115","author":"MS McMurtry","year":"2005","unstructured":"McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Puttagunta L, Michelakis ED: Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest. 2005, 115 (6): 1479-1491. 10.1172\/JCI23203.","journal-title":"J Clin Invest"},{"issue":"79","key":"1152_CR36","first-page":"2040","volume":"54","author":"M Montorsi","year":"2007","unstructured":"Montorsi M, Maggioni M, Falleni M, Pellegrini C, Donadon M, Torzilli G, Santambrogio R, Spinelli A, Coggi G, Bosari S: Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Hepatogastroenterology. 2007, 54 (79): 2040-2044.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"1152_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcpa.2008.02.001","volume":"139","author":"M Murakami","year":"2008","unstructured":"Murakami M, Sakai H, Kodama A, Mori T, Maruo K, Yanai T, Masegi T: Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours. J Comp Pathol. 2008, 139 (1): 1-7. 10.1016\/j.jcpa.2008.02.001.","journal-title":"J Comp Pathol"},{"issue":"4","key":"1152_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/annonc\/mdj121","volume":"17","author":"BM Ryan","year":"2006","unstructured":"Ryan BM, Konecny GE, Kahlert S, Wang HJ, Untch M, Meng G, Pegram MD, Podratz KC, Crown J, Slamon DJ, et al: Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol. 2006, 17 (4): 597-604. 10.1093\/annonc\/mdj121.","journal-title":"Ann Oncol"},{"key":"1152_CR39","volume-title":"Faseb J","author":"S Sakao","year":"2005","unstructured":"Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF: Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. Faseb J. 2005"},{"issue":"21","key":"1152_CR40","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1074\/jbc.M513810200","volume":"281","author":"N Zhu","year":"2006","unstructured":"Zhu N, Gu L, Findley HW, Chen C, Dong JT, Yang L, Zhou M: KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J Biol Chem. 2006, 281 (21): 14711-14718. 10.1074\/jbc.M513810200.","journal-title":"J Biol Chem"},{"issue":"15","key":"1152_CR41","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1242\/dev.021964","volume":"135","author":"H Wan","year":"2008","unstructured":"Wan H, Luo F, Wert SE, Zhang L, Xu Y, Ikegami M, Maeda Y, Bell SM, Whitsett JA: Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development. 2008, 135 (15): 2563-2572. 10.1242\/dev.021964.","journal-title":"Development"},{"issue":"8","key":"1152_CR42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1164\/rccm.200810-1662OC","volume":"180","author":"M Toshner","year":"2009","unstructured":"Toshner M, Voswinckel R, Southwood M, Al-Lamki R, Howard LS, Marchesan D, Yang J, Suntharalingam J, Soon E, Exley A, et al: Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009, 180 (8): 780-787. 10.1164\/rccm.200810-1662OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1152_CR43","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1248\/bpb.31.1609","volume":"31","author":"M Kumekawa","year":"2008","unstructured":"Kumekawa M, Fukuda G, Shimizu S, Konno K, Odawara M: Inhibition of monocyte chemoattractant protein-1 by Kruppel-like factor 5 small interfering RNA in the tumor necrosis factor- alpha-activated human umbilical vein endothelial cells. Biol Pharm Bull. 2008, 31 (8): 1609-1613. 10.1248\/bpb.31.1609.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"1152_CR44","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1172\/JCI24403","volume":"115","author":"Y Zhan","year":"2005","unstructured":"Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P: Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest. 2005, 115 (9): 2508-2516. 10.1172\/JCI24403.","journal-title":"J Clin Invest"},{"issue":"1","key":"1152_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1074\/jbc.M306621200","volume":"279","author":"K Aizawa","year":"2004","unstructured":"Aizawa K, Suzuki T, Kada N, Ishihara A, Kawai-Kowase K, Matsumura T, Sasaki K, Munemasa Y, Manabe I, Kurabayashi M, et al: Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB. J Biol Chem. 2004, 279 (1): 70-76.","journal-title":"J Biol Chem"},{"key":"1152_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-1-60761-500-2_11","volume":"661","author":"J Rehman","year":"2010","unstructured":"Rehman J, Archer SL: A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. Adv Exp Med Biol. 2010, 661: 171-185. 10.1007\/978-1-60761-500-2_11.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"1152_CR47","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1158\/1541-7786.MCR-08-0525","volume":"7","author":"A Mori","year":"2009","unstructured":"Mori A, Moser C, Lang SA, Hackl C, Gottfried E, Kreutz M, Schlitt HJ, Geissler EK, Stoeltzing O: Up-regulation of Kruppel-like factor 5 in pancreatic cancer is promoted by interleukin-1 beta signaling and hypoxia-inducible factor-1 alpha. Mol Cancer Res. 2009, 7 (8): 1390-1398. 10.1158\/1541-7786.MCR-08-0525.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1152_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","volume":"105","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009, 105 (2): 158-166. 10.1161\/CIRCRESAHA.109.197517.","journal-title":"Circ Res"},{"key":"1152_CR49","volume-title":"Arterioscler Thromb Vasc Biol","author":"P Caruso","year":"2010","unstructured":"Caruso P, Maclean MR, Khanin R, McClure J, Soon E, Southwood M, McDonald RA, Greig JA, Robertson KE, Masson R, et al: Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension Due to Chronic Hypoxia and Monocrotaline. Arterioscler Thromb Vasc Biol. 2010"},{"key":"1152_CR50","volume-title":"J Exp Med","author":"A Courboulin","year":"2011","unstructured":"Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, et al: Role for miR-204 in human pulmonary arterial hypertension. J Exp Med. 2011"},{"issue":"11","key":"1152_CR51","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","volume":"123","author":"R Paulin","year":"2011","unstructured":"Paulin R, Courboulin A, Meloche J, Mainguy V, Dumas de la Roque E, Saksouk N, Cote J, Provencher S, Sussman MA, Bonnet S: Signal transducers and activators of transcription-3\/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation. 2011, 123 (11): 1205-1215. 10.1161\/CIRCULATIONAHA.110.963314.","journal-title":"Circulation"},{"issue":"4","key":"1152_CR52","doi-asserted-by":"publisher","first-page":"L729","DOI":"10.1152\/ajplung.00087.2009","volume":"297","author":"PB Sehgal","year":"2009","unstructured":"Sehgal PB, Mukhopadhyay S, Patel K, Xu F, Almodovar S, Tuder RM, Flores SC: Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol. 2009, 297 (4): L729-737. 10.1152\/ajplung.00087.2009.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"1152_CR53","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","volume":"104","author":"M Brock","year":"2009","unstructured":"Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC: Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway. Circ Res. 2009, 104 (10): 1184-1191. 10.1161\/CIRCRESAHA.109.197491.","journal-title":"Circ Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-128\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:30:16Z","timestamp":1630499416000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-128","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"15 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"128"}}